Skip to main content Accessibility help
×
Home

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa

  • Erico A.G. Arruda (a1), Ivan S. Marinho (a1), Marcos Boulos (a1), Sumiko I. Sinto (a1), Helio H. Caiaffa F (a1), Caio M. Mendes (a1), Carmen P. Oplustil (a1), Helio Sader (a2), Carlos E. Levy (a3) and Anna S. Levin (a1)...

Abstract

A case-control study was done to evaluate factors associated with nosocomial infections by multiresistant Pseudomonas aeruginosa (MRPA). Results showed that MRPA was associated with the use of immunosuppressive and antimicrobial drugs. Five typing methods indicated that the MRPA infections were due to multiple strains rather than a single strain.

Copyright

Corresponding author

Rua Harmonia, 564/52, São Paulo - SP 05435-000, Brazil

References

Hide All
1. Gaynes, PR, Culver, DH. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:1014.
2. Garner, JS, Jarvis, WR, Emori, TG. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128140.
3. Knaus, WA, Draper, EA, Wagner, DP, Zimmerman, JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818829.
4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standards. 1990;M2T4. Abstract.
5. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved standards. 1990;M7A2. Abstract.
6. Tenover, FC. Plasmid fingerprint of gram-negative organisms. In Isenberg, HD, ed. Clinical Microbiology Procedures Handbook. Washington, DC: ASM; 1992.
7. Kunin, CM. Resistance to antimicrobial drugs—a worldwide calamity. Ann Intern Med 1993;118:557561.
8. McGowan, JE Jr. Antibiotic-resistant bacteria and healthcare system: four steps for effective response. Infect Control Hosp Epidemiol 1995;16:6770.
9. Krcmery, V Jr, Trup, J, Kunova, A, Spanik, S, Drgona, L, Oravcova, E, et al. Imipenem-resistant Pseudomonas aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res 1996;16:4349.
10. Döring, G, Hörz, M, Ortelt, J, Grupp, H, Wolz, C. Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit. Epidemiol Infect 1993;110:427436.

Related content

Powered by UNSILO

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa

  • Erico A.G. Arruda (a1), Ivan S. Marinho (a1), Marcos Boulos (a1), Sumiko I. Sinto (a1), Helio H. Caiaffa F (a1), Caio M. Mendes (a1), Carmen P. Oplustil (a1), Helio Sader (a2), Carlos E. Levy (a3) and Anna S. Levin (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.